07:00 , Oct 30, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer HER2 (EGFR2; ErbB2; neu); Erbb2 interacting protein (ERBB2IP; ERBIN) Cell-based, primary tumor and mouse...
07:00 , Jun 5, 2014 |  BC Innovations  |  Distillery Techniques

Technology: Drug platforms

Approach Summary Licensing status Publication and contact information Drug platforms Adoptive cell therapy using mutation-specific, CD4+ T cells in epithelial cancer A single-patient study suggests adoptive cell therapy using...
07:00 , May 29, 2014 |  BC Innovations  |  Cover Story

Personalized medicine gets personal

Epithelial cancers are the most common malignancies, but immunotherapy development has been stymied because of the difficulty in identifying targets that are not expressed on normal tissues. A National Cancer Institute team has now used...